EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mitochondrial dysfunction and mitophagy blockade contribute to renal osteodystrophy in chronic kidney disease-mineral bone disorder

Shun-Neng Hsu, Louise A Stephen, Kanchan Phadwal, Scott Dillon, Roderick Carter, Nicholas M Morton, Ineke Luijten, Katie Emelianova, Anish K Amin, Vicky E Macrae, Tom C Freeman, Yu-Juei Hsu und 2 weitere

Kidney International · 2025

DOI: 10.1016/j.kint.2025.01.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2025. Verfasst von Shun-Neng Hsu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Functional Genetics, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian…. Hauptthemen laut MEDLINE: Mitophagy, Chronic Kidney Disease-Mineral and Bone Disorder, Mitochondria, Osteocytes. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Research Council, Tri-Service General Hospital, BBSRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease-mineral and bone disorder (CKD-MBD) presents with extra-skeletal calcification and renal osteodystrophy (ROD). However, the pathophysiology of ROD remains unclear. Here we examine the hypothesis that stalled mitophagy within osteocytes of CKD-MBD mouse models contributes to bone loss. RNA-seq analysis revealed an altered expression of genes associated with mitophagy and mitochondrial function in tibia of CKD-MBD mice. The expression of mitophagy regulators, p62/SQSTM1, ATG7 and LC3, was inconsistent with functional mitophagy, and in mito-QC reporter mice with ROD, there was a two- to three-fold increase in osteocyte mitolysosomes. To determine if uremic toxins were potentially responsible for these observations, treatment of cultured osteoblasts with uremic toxins revealed increased mitolysosome number and mitochondria with distorted morphology. Membrane potential and oxidative phosphorylation were also decreased, and oxygen-free radical production increased. The altered p62/SQSTM1 and LC3-II expression was consistent with impaired mitophagy machinery, and the effects of uremic toxins were reversible by rapamycin. A causal link between uremic toxins and the development of mitochondrial abnormalities and ROD was established by showing that a mitochondria-targeted antioxidant (MitoQ) and the charcoal adsorbent AST-120 were able to mitigate the uremic toxin-induced mitochondrial changes and improve bone health. Overall, our study shows that impaired clearance of damaged mitochondria may contribute to the ROD phenotype. Targeting uremic toxins, oxygen-free radical production and the mitophagy process may offer novel routes for intervention to preserve bone health in patients with CKD-MBD. This would be timely as our current armamentarium of anti-fracture medications for patients with severe CKD-MBD is limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitophagyChronic Kidney Disease-Mineral and Bone DisorderMitochondriaOsteocytesRenal Insufficiency, ChronicAnimalsMiceSequestosome-1 ProteinDisease Models, AnimalOsteoblastsMicrotubule-Associated ProteinsCells, CulturedAutophagy-Related Protein 7HumansMaleUremiaMice, Inbred C57BL

Stichwörter der Autor:innen

CKD-MBDautophagybonemitophagyrenal osteodystrophyuremic toxins

Substanzen

Sequestosome-1 ProteinSqstm1 protein, mouseMicrotubule-Associated ProteinsAutophagy-Related Protein 7Atg7 protein, mouseMap1lc3b protein, mouse

Autor:innen und Institutionen

  • Division of Functional Genetics, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, UK; Division of Nephrology, Department of Internal Medicine, Tri-Ser…
  • Division of Functional Genetics, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, UK.
  • Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
  • UK Dementia Research Institute, University of Edinburgh, Edinburgh Medical School, Edinburgh, UK; Centre for Discovery Brain Sciences, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.
  • Edinburgh Orthopaedics, Royal Infirmary of Edinburgh, Edinburgh, UK.
  • Division of Functional Genetics, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, UK; School of Life Sciences, Faculty of Science and Engineering, Ang…

Förderung

  • Medical Research Council
  • Tri-Service General Hospital
  • BBSRC
  • Ministry of Science and Technology, Taiwan
  • Troy Community Foundation
  • Taiwan Ministry of Science and Technology
  • Wellcome Trust
  • University of Edinburgh

Zitieren

APA

Hsu, S. N., Stephen, L. A., Phadwal, K., Dillon, S., Carter, R., Morton, N. M., Luijten, I., Emelianova, K., Amin, A. K., Macrae, V. E., Freeman, T. C., Hsu, Y. J., Staines, K. A., & Farquharson, C. (2025). Mitochondrial dysfunction and mitophagy blockade contribute to renal osteodystrophy in chronic kidney disease-mineral bone disorder. Kidney International. https://doi.org/10.1016/j.kint.2025.01.022

Vancouver

Hsu SN, Stephen LA, Phadwal K, Dillon S, Carter R, Morton NM, et al. Mitochondrial dysfunction and mitophagy blockade contribute to renal osteodystrophy in chronic kidney disease-mineral bone disorder. Kidney International. 2025. doi:10.1016/j.kint.2025.01.022

BibTeX
@article{Hsu2025,
  author = {Hsu, Shun-Neng and Stephen, Louise A and Phadwal, Kanchan and Dillon, Scott and Carter, Roderick and Morton, Nicholas M and Luijten, Ineke and Emelianova, Katie and Amin, Anish K and Macrae, Vicky E and Freeman, Tom C and Hsu, Yu-Juei and Staines, Katherine A and Farquharson, Colin},
  title = {Mitochondrial dysfunction and mitophagy blockade contribute to renal osteodystrophy in chronic kidney disease-mineral bone disorder},
  journal = {Kidney International},
  year = {2025},
  doi = {10.1016/j.kint.2025.01.022}
}
Kostenlos starten →